Skip to main content
OpenTrials

Clinical trial condition

Genital Diseases, Male

Explore clinical trials studying Genital Diseases, Male. Study availability and eligibility vary by location and protocol.

6,750 public trials 1,242 recruiting studies
Refine in advanced search Browse all conditions

Genital Diseases, Male trial results

Active, Not Recruiting

Study of Abiraterone Acetate or Enzalutamide, Atezolizumab, GnRH Analog and Radiation Therapy in Men With Newly Diagnosed Hormone-sensitive Prostate Cancer

NCT04262154

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Active, Not Recruiting

Nivolumab in Patients With High-Risk Biochemically Recurrent Prostate Cancer

NCT03637543

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • St. Elizabeth's Medical Center Boston, Massachusetts, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • DFCI South Shore South Weymouth, Massachusetts, United States
View Trial Details
Active, Not Recruiting

Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

NCT01368588

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
  • Anchorage Oncology Centre Anchorage, Alaska, United States
View all 478 locations
View Trial Details
Active, Not Recruiting

Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

NCT04136353

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute - St. Elizabeth's Brighton, Massachusetts, United States
  • Lahey Hospital and Medical Center Burlington, Massachusetts, United States
  • Dana Farber Cancer Institute - Milford Milford, Massachusetts, United States
View all 93 locations
View Trial Details

Related conditions